Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1979;60:131-141

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernhard, W. F.
Right arrow Articles by Fishbein, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernhard, W. F.
Right arrow Articles by Fishbein, M. C.

Circulation, Vol 60, 131-141, Copyright © 1979 by American Heart Association


ARTICLES

Temporary left ventricular bypass: factors affecting patient survival

WF Bernhard, RL Berger, JP Stetz, JG Carr, NA Colo, JR McCormick and MC Fishbein

Circulatory support (range, 2 hours-8 days) was undertaken in eight cardiac surgical patients (with two survivors) exhibiting intractable cardiogenic shock. A paracorporeal, pneumatic, xenograft-valve pump was interposed between the left ventricular apex and ascending aorta. Pumping lowered left atrial and ventricular pressure while maintaining cardiac output (1.8--2.6 l/min/m2). Following implantation, plasma hemoglobin and erythrocyte mechanical fragility values were elevated but decreased to normal when renal function was not impaired. Mild thrombocytopenia was noted in three patients and was severe in five others with persistent hemorrhage. Anticoagulation agents were used during tapering of pump flow (three patients) after 100, 105 and 120 hours of bypass. Otherwise, for the major portion of the interval of mechanical circulatory support, anticoagulants were not administered. Despite this fact, no systemic embolization was detected in any of the patients. It appears that assist pump support can be life-saving in acute left ventricular failure in patients following cardiac surgery.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
H. Takano and T. Nakatani
Ventricular Assist Systems: Experience in Japan With Toyobo Pump and Zeon Pump
Ann. Thorac. Surg., January 1, 1996; 61(1): 317 - 322.
[Abstract] [Full Text]


Home page
J Biomater ApplHome page
A. A. Lefemine and J. Dunbar
Simple Alternatives Using a Single Centrifugal Pump for Biventricular Assistance in Cardiogenic Shock
J Biomater Appl, April 1, 1990; 4(4): 333 - 361.
[Abstract] [PDF]


Home page
PerfusionHome page
J. Chalmers and T. Graham
Review article : Mechanical ventricular support in the management of postcardiotomy cardiogenic shock
Perfusion, October 1, 1989; 4(4): 243 - 253.
[Abstract] [PDF]


Home page
JAMAHome page
R. L. Berger, J. R. McCormick, J. D. Stetz, M. D. Klein, T. J. Ryan, J. Carr, S. Sweet, and W. F. Bernhard
Successful Use of a Paracorporeal Left Ventricular Assist Device in Man
JAMA, January 4, 1980; 243(1): 46 - 49.
[Abstract] [PDF]